In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on scPharmaceuticals (SCPH – Research Report). The company’s shares closed yesterday at $6.36.
Knickerbocker covers the Healthcare sector, focusing on stocks such as Fennec Pharmaceuticals, Xeris Pharmaceuticals, and MiMedx Group. According to TipRanks, Knickerbocker has an average return of 24.7% and a 75.00% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for scPharmaceuticals with a $20.00 average price target, a 214.47% upside from current levels. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $18.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Based on scPharmaceuticals’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $3.8 million and a GAAP net loss of $15.63 million. In comparison, last year the company had a GAAP net loss of $10.16 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
scPharmaceuticals (SCPH) Company Description:
scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.
Read More on SCPH:
- scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue
- scPharmaceuticals management to meet virtually with Craig-Hallum
- scPharmaceuticals management to meet virtually with Maxim
- scPharmaceuticals management to meet with Maxim
- scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
